Published in Am J Obstet Gynecol on August 01, 1991
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol (2006) 3.68
Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer (2007) 2.36
The reporting of HIV/AIDS deaths in women. Am J Public Health (1992) 1.89
Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ (1999) 1.63
Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings. AIDS Res Treat (2012) 1.21
Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol (2002) 1.14
The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus. Infect Agent Cancer (2009) 1.10
A study of anal intraepithelial neoplasia in HIV positive homosexual men. Sex Transm Infect (1999) 1.03
Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe. J Infect Dis (2011) 1.01
Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasia. Ann Behav Med (2008) 0.92
Pathogenesis of genital HPV infection. Genitourin Med (1993) 0.87
Smoking and cervical cancer. ISRN Obstet Gynecol (2011) 0.87
Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth. J Virol (2000) 0.87
A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy. Infect Dis Obstet Gynecol (1999) 0.86
HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J Virol (2003) 0.85
Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females. PLoS One (2012) 0.84
Gynecologic issues in the HIV-infected woman. Infect Dis Clin North Am (2008) 0.83
Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma. Am J Pathol (1994) 0.81
Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals. Sex Transm Infect (1998) 0.79
Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia. Am J Pathol (1994) 0.78
Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort. J Pediatr Adolesc Gynecol (2011) 0.77
Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med (1998) 11.61
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
Transmission of the human immunodeficiency virus. N Engl J Med (1987) 4.17
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst (2000) 3.81
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15
Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst (1999) 2.98
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med (1985) 2.62
Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol (1992) 2.56
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst (1982) 2.28
The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol (1993) 2.27
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis (2000) 2.24
Survival differences in patients with AIDS. J Acquir Immune Defic Syndr (1991) 2.23
Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20
Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer (1991) 2.19
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A (1986) 2.18
Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med (1979) 2.06
[On a bound gibberellin from Phaseolus coccineus L]. Experientia (1964) 2.05
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst (2001) 1.86
Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis (2001) 1.77
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev (2001) 1.77
A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc Natl Acad Sci U S A (1998) 1.77
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Concerns of medical and pediatric house officers about acquiring AIDS from their patients. Am J Public Health (1988) 1.70
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr (1999) 1.61
Cervicovaginal human papillomavirus infection in suburban adolescents and young adults. J Pediatr (1991) 1.58
Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology (1987) 1.57
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica. Br J Cancer (2003) 1.55
Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med (1996) 1.54
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer (2001) 1.52
Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol (2001) 1.51
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Molecular diagnosis of genital human papillomavirus infection: comparison of two methods used to collect exfoliated cervical cells. Am J Obstet Gynecol (1989) 1.51
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol (1995) 1.48
Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47
Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol (1987) 1.47
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol (1997) 1.44
Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstet Gynecol (1984) 1.43
Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial. Neurology (2007) 1.43
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. Br J Cancer (2004) 1.40
Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1992) 1.40
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res (1996) 1.39
Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Proc Natl Acad Sci U S A (2000) 1.36
Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 1.36
Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Ann Intern Med (1989) 1.35
The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology (1988) 1.34
VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling. Mol Cell Biol (2001) 1.31
Human papillomavirus, gonorrhea, syphilis, and cervical dysplasia in jailed women. Am J Public Health (1991) 1.31
Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Antimicrob Agents Chemother (1979) 1.30
HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer (1998) 1.29
The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med (1985) 1.29
Gene expression profiles in HPV-infected head and neck cancer. J Pathol (2007) 1.27
Inter-laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer (1989) 1.27
High prevalence rate of human papillomavirus infection and association with abnormal papanicolaou smears in sexually active adolescents. Am J Dis Child (1989) 1.27
Characterization and evolution of a single-copy sequence from the human Y chromosome. Mol Cell Biol (1985) 1.25
Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol (1986) 1.24
Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23
Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol (1987) 1.23
Immunologic distribution of an organic anion transport protein in rat liver and kidney. Am J Physiol (1996) 1.22
Time to peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol (1996) 1.22
Infectious diarrhea in patients with AIDS. Dig Dis Sci (1988) 1.22
Point mutation in essential genes with loss or mutation of the second allele: relevance to the retention of tumor-specific antigens. J Exp Med (2001) 1.20
Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis (1994) 1.19
Human papillomavirus type 13 and pygmy chimpanzee papillomavirus type 1: comparison of the genome organizations. Virology (1992) 1.18
Endogenous plant hormones of the broad bean, Vicia faba L. (-)-jasmonic acid, a plant growth inhibitor in pericarp. Planta (1981) 1.18
A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17
The relation of type 2 diabetes and cancer. Diabetes Technol Ther (2001) 1.16
Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J Clin Microbiol (1997) 1.16
Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents. Gastroenterology (1996) 1.15
Elimination of false-positive signals in enhanced chemiluminescence (ECL) detection of amplified HPV DNA from clinical samples. Biotechniques (1995) 1.14
Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis (2001) 1.14
Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst (1997) 1.13
Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res (1996) 1.12
Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein. J Exp Med (2000) 1.12